Mannose metabolism inhibition sensitizes acute myeloid leukemia cells to cytarabine and FLT3 inhibitor therapy by modulating fatty acid metabolism to drive ferroptotic cell death.

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Cancer Oncology

Immunology

Show all topics

DOI

10.1101/2022.05.16.492042

License

CC-BY-NC-ND

Other Formats

PDF